ResMed (RMD)

Cost of Revenue

$2.20B

TTM · Period ending: · USD

RMD logo

RMD Cost of Revenue

Latest reported$2.20B
RMD TTM Cost of Revenue ($0.00 → $2.20B)
High-resolution chart · PNG

RMD cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

ResMed Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
2,195,765,000
2,121,260,000
2,106,161,000
2,098,827,000
2,091,355,000
2,082,362,000
2,072,437,000
2,035,023,000
2,029,994,000
2,015,735,000
1,999,478,000
1,960,107,000
1,867,330,000
1,754,890,000
1,629,047,000
1,565,574,000
1,553,816,000
1,546,992,000
1,495,198,000
1,442,170,000
1,357,727,000
1,293,291,000
1,291,575,000
1,263,074,000
1,225,792,000
1,191,935,000
1,142,460,000
1,100,802,000
1,069,987,000
1,044,032,000
1,021,053,000
1,005,165,000
978,033,000
949,784,000
916,935,000
886,780,000
864,992,000
849,240,000
828,749,000
795,454,000
772,216,000
748,692,000
725,759,000
697,458,000
667,516,000
627,835,000
602,739,000
578,591,000
565,185,000
565,991,000
564,153,000
572,396,000
573,799,000
564,500,000
558,945,000
549,143,000
547,780,000
545,341,000
537,520,000
523,484,000
501,822,000
475,856,000
457,176,000
448,118,000
436,874,000
415,070,000
391,916,000
372,942,000
366,932,000
372,748,000
369,095,000
358,488,000
341,647,000
314,683,000
358,172,000
343,494,000
331,840,000
324,725,000
257,381,000
245,401,000
230,100,000
208,761,000
185,506,000
166,331,000
150,645,000
138,283,000
133,851,000
128,204,000
122,602,000
119,646,000
111,728,000
105,314,000
100,483,000
89,591,000
82,787,000
76,420,000
70,827,000
72,376,000
65,163,000
57,642,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.